A box of Evusheld, an antibody therapy developed by pharmaceutical company AstraZeneca for the prevention of COVID-19 in immunocompromised patients, is seen in February at the AstraZeneca facility for biological medicines in Sweden Jonathan Nackstrand/AFP via Getty Images The federal government is trying to make it easier for immunocompromised patients access a treatment that can protect them against COVID-19 by allowing individual health care providers to order small amounts up to three patient courses at a time, according to a Health and Human Services Department spokesperson.
#information #getty-images #biden-administration #spokesperson #federal-government #astrazeneca #million-doses #rural-areas
[
add
]
[
|
|
...
]